Owner Roivant Sciences Ltd Buys 16,666,666 ($350M) Of Immunovant Inc [IMVT]
Roivant Sciences Ltd Beneficial Owner of Immunovant Inc [IMVT] filed a Form 4 on December 12, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/12/25TransactionPurchaseShares16,666,666Price$21.00Value$349,999,986Ending Holdings: 113,317,007 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.
Reuters·